Effects of fluid challenge on gastric mucosal PCO2 in septic patients

Intensive Care Med. 2004 Mar;30(3):423-9. doi: 10.1007/s00134-003-2115-2. Epub 2004 Jan 13.

Abstract

Objective: To determine the effects of fluid challenge on systemic hemodynamic variables and gastric intramucosal partial pressure of carbon dioxide (PCO(2)) in septic patients.

Design: Short-term interventional study.

Setting: Medical-surgical intensive care unit in a university hospital.

Patients: Twenty-four adult patients with severe sepsis or septic shock requiring volume replacement. All patients were studied within 24 h of onset of severe sepsis or septic shock.

Interventions: Five hundred milliliters of a 6% hydroxyethyl starch (HES) solution were administered in 30 min.

Measurements and results: Complete hemodynamic data, blood samples, and gastric mucosal PCO(2) (automatic gas capnometry) determinations were obtained at baseline and 15 min after the end of fluid infusion. After fluid challenge, cardiac index (CI) increased from 3.8 (range 2.9-4.2) to 4.2 (range 3.1-4.9) l/min m(-2) ( p<0.05). The PCO(2) gap decreased from 9.8 (range 6.9-26.0) to 8.5 (range 6.6-17.4) mm Hg ( p<0.05), but important individual variations were observed. We failed to observe significant relationships between changes in CI and in PCO(2) gap, or between indices of preload (pulmonary artery occluded pressure, right atrial pressure, and pulse pressure variations) and changes in PCO(2) gap. In addition, changes in PCO(2) gap and in (v-a) CO(2) were not related; however, changes in PCO(2) gap were related to baseline PCO(2) gap ( p=0.003), PEEP ( p=0.02), and cumulative doses of vasopressors ( p=0.02).

Conclusions: The effects of fluid challenge on gastric mucosal PCO(2) are variable and related to baseline PCO(2) gap rather than to systemic variables. In general, rapid volume infusion decreases PCO(2) gap, but this effect is more pronounced in patients with presumably impaired mucosal perfusion.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carbon Dioxide / metabolism*
  • Female
  • Fluid Therapy / methods*
  • Gastric Mucosa / metabolism*
  • Humans
  • Hydroxyethyl Starch Derivatives / therapeutic use
  • Linear Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Partial Pressure
  • Plasma Substitutes / therapeutic use
  • Prospective Studies
  • Shock, Septic / therapy*
  • Systemic Inflammatory Response Syndrome / therapy*

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Carbon Dioxide